This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of cow's milk protein allergy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Dietary advice:

IgE mediated cow's milk protein allergy

  • managed via secondary care - a diet free from cow’s milk protein. Exclude all cow’s milk and products

non-IgE mediated cow's milk protein allergy

  • Dietary management involves removing the allergenic protein from the diet
    • all dairy products must be removed from the diet of a breastfeeding mother if milk allergy is suspected in the infant and calcium supplements given
    • in a formula-fed infant, choice of formula is determined by the severity of the symptoms
      • most infants respond to extensively hydrolysed formulas, where the milk protein is broken down
      • amino acid formulas should be reserved for severe symptoms and those not responding to an extensively hydrolysed formula
        • should also be used first line if top-up feeds are required in an infant who is exclusively breast fed and shows symptoms suggestive of cow’s milk allergy
    • acquisition of tolerance in cow’s milk allergy should be considered after at least 6 months on a diet free from milk protein
      • likely that tolerance to extensively baked milk products will occur before that to less well cooked milk
  • refer to secondary care only if symptoms severe (4)

Flow chart for managing cow's milk protein allergy:

 

Prescribing information:

 

Cow’s Milk Protein Allergy additional notes (1,2,3)

  • soya is not recommended before 6 months of age due to it containing isoflavones, which may exert a weak oestrogenic effect. There is also a risk of cross-reactivity: up to 14% of those with IgE-mediated cow’s milk allergy also react to soya and up to 60% of those with non-IgE-mediated cow’s milk allergy
  • rice milk is not recommended in those aged <4.5 years due to the arsenic content; and there is cross-reaction between mammalian milks
  • goat’s milk and products are not suitable for infants with cow’s milk allergy
  • breastfeeding is the optimal way to feed a baby with CMPA, with, if required, individualised maternal elimination of all cow’s milk protein foods (+ Calcium and vitamin D supplementation).
  • CMPA commonly appear when a formula is introduced in a usually breastfed baby. Therefore returning to exclusive breastfeeding should be discussed and encouraged at the earliest opportunity
  • in the UK, 2-3% of 1-3year olds have confirmed CMPA (the highest prevalence in Europe)
  • only about 10% of babies with CMPA will require an AAF (amino-acid free). The remainder should tolerate an EHF
  • 10-14% of infant with CMPA will also react to soya proteins (and up to 50% of those with non-IgE mediated CMPA). But because of better palatability soya formula is worth considering in babies>6months

Reference:

  • Walsh J et al. Differentiating milk allergy (IgE and non-IgE mediated) from lactose intolerance: understanding the underlying mechanisms and presentations. Br J Gen Pract 2016; DOI: 10.3399/bjgp16X686521
  • Ludman S, Shah N, Fox AT. Managing cow’s milk allergy in children. BMJ 2013; 347: f5424.
  • Wessex Infant Feeding Guidelines and Appropriate Prescribing of Specialist Infant Formulae (Accessed 8/3/2020)
  • NHS Fife. Diagnosis and Management of Infants with Suspected Cow’s Milk Protein Allergy. A guide for healthcare professionals working in primary care (Accessed 8/3/2020)

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.